atugen, Sanofi-Aventis siRNA deal

atugen (Berlin, Germany) and Sanofi- Aventis (Euronext:SAN; SNY) partnered to develop siRNA therapeutics using atugen's functional gene silencing technologies. atugen is using its oligonucleotide deli...